#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3631861	B	Inhibition of 5-LO in mouse BMM cells assessed as formation of LTC4 after 30 mins by enzyme immunoassay	Mus musculus	4		cell-based format	Scientific Literature
2.	ALA3631862	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of RANKL-induced osteoclasts differentiation by measuring TRAP positive multinucleated cells after 4 days by light microscopy	Mus musculus	4		cell-based format	Scientific Literature
3.	ALA3631863	A	Cytotoxicity against mouse BMM cells assessed as cell survival after 4 days by MTT assay	Mus musculus	1		cell-based format	Scientific Literature
4.	ALA3631864	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of M-CSF and RANKL-induced formation of bone resorption pits at 10 uM after 2 days by toluidine blue staining based bone resorption assay	Mus musculus	1		cell-based format	Scientific Literature
5.	ALA3631865	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of RANKL-induced ATP6V0D2 mRNA expression at 10 uM after 4 days by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
6.	ALA3631866	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of RANKL-induced alpha v-integrin mRNA expression at 10 uM after 4 days by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
7.	ALA3631867	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of RANKL-induced cathepsin K mRNA expression at 10 uM after 4 days by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
8.	ALA3631868	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of RANKL-induced DC-STAMP mRNA expression at 10 uM after 4 days by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
9.	ALA3632397	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of RANKL-induced beta3-integrin mRNA expression at 10 uM after 4 days by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
10.	ALA3632398	B	Inhibition of MAPK/NF-kappaB in mouse BMM cells assessed as down regulation of RANKL-induced NFATc1 expression at 10 uM pre-treated for 30 mins before RANKL-stimulation for 24 hrs by Western blot analysis	Mus musculus	1		cell-based format	Scientific Literature
11.	ALA3632399	F	Antiosteoclast activity in mouse BMM cells over-expressing constitutively active NFATc1 assessed as suppression of RANKL-induced osteoclast formation at 10 uM after 4 days by TRAP+ staining based method	Mus musculus	1		cell-based format	Scientific Literature
12.	ALA3632400	B	Inhibition of ERK phosphorylation in mouse BMM cells at 10 uM pre-incubated for 30 mins before RANKL-stimulation for 15 mins by Western blot analysis	Mus musculus	1		cell-based format	Scientific Literature
13.	ALA3632401	B	Inhibition of p38 phosphorylation in mouse BMM cells at 10 uM pre-incubated for 30 mins before RANKL-stimulation for 15 mins by Western blot analysis	Mus musculus	1		cell-based format	Scientific Literature
14.	ALA3632402	B	Inhibition of NFkappaB in mouse BMM cells assessed as suppression of RANKL-induced IkappaB degradation at 10 uM pre-incubated for 30 mins before RANKL-stimulation for 15 mins by Western blot analysis	Mus musculus	1		cell-based format	Scientific Literature
15.	ALA3632403	F	Antiosteoclast activity in mouse BMM cells assessed as reduction of LPS-induced osteoclast formation at 10 uM after 4 days by TRAP+ staining based light microscopy	Mus musculus	1		cell-based format	Scientific Literature
16.	ALA3632404	F	Antiosteoclast activity in mouse assessed as reduction of LPS-induced osteoclast formation in calvarial bone at 5 mg/kg, ip administered daily with LPS challenge after first day of compound dosing measured 6 days after LPS injection	Mus musculus	1		organism-based format	Scientific Literature